Skip to content

Reducing maternal anaemia in Chandigarh through mobile-based personalized advice on diet and medications.

Effectiveness of m-health based digital interventions for personalized counselling on nutrition and medication adherence in the reduction of maternal anemia in Chandigarh: a randomized control trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099599
Enrollment
218
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Pregnant women and the selected caregiver will be provided m-health based personalized counselling on nutrition and medication adherence in addition to the standard antenatal care from

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -Pregnant women registered in the selected health facilities for antenatal care. -Resident of the study area in Chandigarh and willing to stay in the study area till delivery. -Pregnant women having their own smartphones. -A caregiver (husband, mother-in-law, sister-in-law, sister, mother, friend etc.) should be available in the family/neighbourhood to support the pregnant women for compliance. -Participants who will give written informed consent.

Exclusion criteria

Exclusion criteria: -Pregnant women with underlying diseases such as hemoglobinopathy (e.g. thalassemia), chronic diseases (chronic renal disease, cancer), or infectious diseases (HIV, malaria), presented with symptoms of anemia (shortness of breath, chest pain, syncope) during the current pregnancy. -Pregnant women planning termination of pregnancy -Pregnant women diagnosed with severe anaemia with haemoglobin of less than 7 g/dl at the time of recruitment.

Design outcomes

Primary

MeasureTime frame
Mean change of Haemoglobin level (g/dl) from baseline value to post intervention value in both intervention and control group.Timepoint: At baseline assessment i.e. POG up to 12 weeks and at endline assessment after 25 plus two weeks, i.e. POG at 37 plus two weeks.

Secondary

MeasureTime frame
Change in the mean knowledge assessment scores from baseline value to post intervention value in both intervention & control group.Timepoint: At baseline assessment i.e. POG up to 12 weeks & at endline assessment after 25 plus two weeks, i.e. POG at 37 plus two weeks.;Change in the mean medication adherence scores from baseline value to post intervention value in both intervention & control group.Timepoint: At baseline assessment i.e. POG up to 12 weeks & at endline assessment after 25 plus two weeks, i.e. POG at 37 plus two weeks.

Countries

India

Contacts

Public ContactDr Nivedita Chakravarti

PGIMER, Chandigarh

madhugupta21@gmail.com7009769629

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026